Scandi pharma: Swede deal for Psyros Diagnostics
Summary : Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC)…
Summary : Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC)…
Summary : First and only FDA-approved medicine for TED, a serious, progressive, vision-threatening rare disease Clinical improvements were seen as early as…
Synopsis : Using cannabis alongside other drugs may come with a significant risk of harmful drug-drug interactions, new research by scientists at…
Summary : Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor…
Synopsis : Dementia is thought to occur when proteins called amyloid-β, tau, and α-synuclein accumulate in the brain and form oligomers. A…
Synopsis : The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered…
Summary : Selecta Biosciences and Ginkgo Bioworks are extending their alliance to cover gene therapy delivery. Just months after disclosing a rare…
Synopsis : As a British citizen living in England but writing on American drug names, I’m in a perfect position to know…
Summary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…
Summary : The IPO consists of a fresh issue of up to Rs 1,100 crore by the company, which will be used…